show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • Weekly Ad

Oxybutynin: Oral tablet, extended release

Also see:
  • Reported side effects
  • Daily life interactions

Available Strengths
Drug Image file DrugItem_21171.JPG
Oxybutynin 5mg ER Tab
AvKARE, Inc.
Pill Identification: KU  |  270
Drug Image file DrugItem_23188.JPG
Oxybutynin 5mg ER Tab
Major Pharmaceuticals Inc, a Harvard Drug Group Company
Pill Identification: A31 
Drug Image file DrugItem_21172.JPG
Oxybutynin 10mg ER Tab
AvKARE, Inc.
Pill Identification: KU  |  271
Drug Image file DrugItem_21173.JPG
Oxybutynin 15mg ER Tab
AvKARE, Inc.
Pill Identification: KU  |  272
Drug Image file DrugItem_15876.JPG
Oxybutynin 10mg ER Tab
American Health Packaging
Pill Identification: KU  |  271
Drug Image file DrugItem_13644.JPG
Oxybutynin 5mg ER Tab
Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannnett Company. Inc.
Pill Identification: KU  |  270
Drug Image file DrugItem_8619.JPG
Oxybutynin 10mg ER Tab
Mylan Pharmaceuticals Inc.
Pill Identification: M O 10 
Drug Image file DrugItem_8618.JPG
Oxybutynin 5mg ER Tab
Mylan Pharmaceuticals Inc.
Pill Identification: M O 5 
Drug Image file DrugItem_23189.JPG
Oxybutynin 5mg ER Tab
Marlex Pharmaceuticals
Pill Identification: A31 
Drug Image file DrugItem_8617.JPG
Oxybutynin 15mg ER Tab
Teva Pharmaceuticals USA
Pill Identification: G 343 
Drug Image file DrugItem_13642.JPG
Oxybutynin 5mg ER Tab
Teva Pharmaceuticals USA
Pill Identification: G 341 
Drug Image file DrugItem_13643.JPG
Oxybutynin 10mg ER Tab
Teva Pharmaceuticals USA
Pill Identification: G 342 
Drug Image file DrugItem_16147.JPG
Oxybutynin 5mg ER Tab
American Health Packaging
Pill Identification: KU  |  270
Drug Image file DrugItem_23190.JPG
Oxybutynin 5mg ER Tab
AvKARE, Inc.
Pill Identification: A31 
Drug Image file DrugItem_11925.JPG
Oxybutynin 10mg ER Tab
Mylan Institutional LLC
Pill Identification: M O 10 
Drug Image file DrugItem_20741.JPG
Oxybutynin 15mg ER Tab
Patriot Pharmaceuticals, LLC, a wholly owned subsidiary of McNEIL-PPC, Inc
Pill Identification: 15 XL 
Drug Image file DrugItem_20740.JPG
Oxybutynin 10mg ER Tab
Patriot Pharmaceuticals, LLC, a wholly owned subsidiary of McNEIL-PPC, Inc
Pill Identification: 10 XL 
Drug Image file DrugItem_20739.JPG
Oxybutynin 5mg ER Tab
Patriot Pharmaceuticals, LLC, a wholly owned subsidiary of McNEIL-PPC, Inc
Pill Identification: 5 XL 
Drug Image file DrugItem_9542.JPG
Oxybutynin 15mg ER Tab
Mylan Pharmaceuticals Inc.
Pill Identification: M O17 
Drug Image file DrugItem_23191.JPG
Oxybutynin 5mg ER Tab
Amneal Pharmaceuticals LLC
Pill Identification: A31 
Drug Image file DrugItem_15815.JPG
Oxybutynin 15mg ER Tab
AvPAK; a Division of AvKARE Inc
Pill Identification: KU  |  272
Drug Image file DrugItem_15366.JPG
Oxybutynin 5mg ER Tab
McKesson Packaging
Pill Identification: KU  |  270
Drug Image file DrugItem_15814.JPG
Oxybutynin 10mg ER Tab
AvPAK; a Division of AvKARE Inc
Pill Identification: KU  |  271
Drug Image file DrugItem_15787.JPG
Oxybutynin 5mg ER Tab
AvPAK; a Division of AvKARE Inc
Pill Identification: KU  |  270
Drug Image file DrugItem_14635.JPG
Oxybutynin 15mg ER Tab
Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannnett Company. Inc.
Pill Identification: KU  |  272
Drug Image file DrugItem_14634.JPG
Oxybutynin 10mg ER Tab
Kremers Urban Pharmaceuticals Inc., a subsidiary of Lannnett Company. Inc.
Pill Identification: KU  |  271
Drug Image file DrugItem_11924.JPG
Oxybutynin 5mg ER Tab
Mylan Institutional LLC
Pill Identification: M O 5 

Frequently Asked Questions (FAQs) on Oxybutynin: Oral tablet, extended release

What is this medicine?

OXYBUTYNIN (ox i BYOO ti nin) is used to treat overactive bladder. This medicine reduces the amount of bathroom visits. It may also help to control wetting accidents.


What should I tell my health care provider before I take this medicine?

How should I use this medicine?

What if I miss a dose?

What may interact with this medicine?

What should I watch for while using this medicine?

What side effects may I notice from receiving this medicine?

Where should I keep my medicine?

CVS Pharmacy Patient Statistics for Oxybutynin: Oral tablet, extended release
Usage by Gender
72.82%
27.18%
Generic vs. Brand Name Usage*
*Brand contains same active ingredient but may not represent FDA-approved generic equivalent
Usage by Age
3.17%
6.37%
25.3%
65.16%
In-Depth Information on This Drug
Select a specific strength to visit the detail page where you'll find :
  • Reported side effects
  • Daily life interactions
Select a Strength
Patient Experiences with Oxybutynin

We want to help you stay educated about the medications you are taking. View other
patient's observations and share your own.

Be sure to consult your health care provider before taking any medications. Other
patient's comments should not be considered medical advice or health care provider
recommendations.